Sandoz Inc. v. AbbVie Biotechnology Ltd > Summary
Court Case Number IPR2017-01987
Filing Date Aug 21, 2017
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesMichelle N. Ankenbrand, Susan L. C. Mitchell, Jacqueline T. Harlow
Judge Writing the Final DecisionMichelle N. Ankenbrand
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6
Petitioner
Patent Owner
Petitioner Attorneys
6Sandoz
Attorney Name: Deborah E. Fishman
Arnold & Porter Kaye Scholer
Sandoz
Attorney Name: David R. Marsh
Arnold & Porter Kaye Scholer
Sandoz
Attorney Name: David K. Barr
Arnold & Porter Kaye Scholer
Sandoz
Attorney Name: Daniel L. Reisner
Arnold & Porter Kaye Scholer
Attorney Name: Abigail Struthers
Arnold & Porter Kaye Scholer
Attorney Name: Victoria Reines
Arnold & Porter Kaye Scholer
Patent Owner Attorneys
5AbbVie Biotechnology
Attorney Name: Michael J. Flibbert
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: Maureen D. Queler
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: William Esper
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: Pier D. Deroo
Finnegan, Henderson, Farabow, Garrett & Dunner
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08911737 | Methods of administering anti-TNFα antibodies | Dec 16, 2014 |
